Insmed (INSM) Misses Q2 EPS by 40c
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q2 EPS of ($1.70), $0.40 worse than the analyst estimate of ($1.30). Revenue for the quarter came in at $107.4 million versus the consensus estimate of $103.41 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Musalem: strong growth and investment influencing bond market - CNBC
- China semiconductor equipment imports grow 9% in July, Barclays comments
- Bernstein upgrades Analog Devices on Q3 beat, improving risk-reward
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
